| Symbol | OPK |
|---|---|
| Name | OPKO HEALTH,INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | BIOMED |
| Address | 4400 BISCAYNE BOULEVARD, MIAMI, Florida, 33137, United States |
| Telephone | 08-9300051 |
| Fax | 08-9543101 |
| gfaibish@opko.com | |
| Website | www.opko.com |
| Incorporation | USA - Delaware |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | TASE;NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | — |
| Description | OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opkos diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a global supply-chain operation and holding company in Ireland. Opko also owns a speciality active pharmaceutical ingredients manufacturer in Israel. The companys bio-reference testing business consists of routine testing and esoteric testing. Routine tests measure various health parameters, such as the functions of the heart, kidney, liver, thyroid, and other organs. Additional info from NASDAQ: |
OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests
Read moreOPKO Health Reports Second Quarter 2026 Business Highlights and Financial Results
Read more